Remicade® (infliximab)

Authorization form

Medicare Part B (01/2021)

Remicade is not covered for Traditional, Optimized or Medicaid

July 1 change: Remicade® infusions no longer covered

All existing approvals for Remicade (J1745) will be given a June 30, 2018 end date.

Read the news article

See the video presentation on biosimilars (13 min.)

For further information on medical drugs, please see the Injectable drugs page.